The Guardian19 Jun 2026Macro
Automatically composed with AI from the cited sources
The study found daughters of mothers with elevated blood levels of two specific PFAS compounds were 2.3 to 2.7 times more likely to develop PMOS or moderate-to-severe acne by their late teens, based on a longitudinal cohort of roughly 325 Boston-area mother-daughter pairs from Project Viva. The associated compounds are N-EtFOSAA, which can degrade into PFOS, and PFNA; the study's authors note the sample size is small and skewed toward white, college-educated participants. The condition was formally renamed from polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) in May to reflect its systemic hormonal nature.